medvi glp 1 is showing what a new kind of company can look like A telehealth platform selling GLP-1 weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B MEDVi - Personalized Telehealth Care
Description
Species-specific action of (Pro3)GIP a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

Leith also shared what keeps her lively as shes set to turn 86 in February

doi: 10.1007/978-3-030-73234-9_36 [DOI] [PubMed] [Google Scholar] 4

Pharmacists could say, You might find it easy to lose weight while youre on this medicine
